Fact CheckerSign in

NCT06688292CompletedPhase 4

The Safety and Effectiveness of Taneasy and Actein in COPD Patients

A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Actein Effervescent Tablets 600MG in COPD Subjects

Source: ClinicalTrials.gov · Last updated 5 Feb 2025

Brief summary (registry, in English)

To evaluate the safety and efficacy of Taneasy 600mg granules and Actein effervescent tablets 600MG administered twice daily for 14 days in treatment of COPD Disease.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
42 (actual)
First submitted
11 Nov 2024
Start date
20 Sept 2024
Primary completion date
31 Dec 2024
Lead sponsor
Bun Yao Biotechnology Co., Ltd
Diseases
COPD
NCT number
NCT06688292

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 42
  • From 20 Sept 2024 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Joining any drug clinical trial within 3 months prior to dosing.

Other illness

  • Subjects with known hypersensitivity to Acetylcysteine preparations.
  • Subjects with other serious medical diseases that are judged by the attending physician to affect the evaluation results (such as: tuberculosis, pneumonia, bronchial asthma, bronchiectasis, cor pulmonale, lung cancer, acute myocardial infarction, acute hepatitis, renal failure, etc.)

Other

  • Pregnancy or breast-feeding woman.
  • Female subjects or their sexual partners do not use contraception during the trial.
  • Investigator considered to be inappropriate for enrollment.
  • Phenylketonuria (PKU).

Who the study is looking for

  • Subjects aged older than 20\~75 years old.
  • Able to sign informed consent prior to the study.
  • Subjects have COPD.

Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Taichung Veterans General Hospital
Coordinator of this site? Confirm its status
TaichungTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.